Resources search

Measuring transparency in the distribution of pharmaceuticals : assessment instrument

DEPARTMENT OF MEDICINES POLICY AND STANDARDS, WORLD HEALTH ORGANIZATION (WHO)
September 2007

Expand view

Distribution is an important activity in the management of pharmaceuticals involving a number of steps between arrival in the port of entry to the point of supply to health establishment, each of which can present various opportunities for lack of transparency and invites corruption. Published standard operating procedures which specify the roles and responsibilities of all staff involved in each of these steps are important tools that promote transparency and accountability

WHO ethical and safety recommendations for researching, documenting and monitoring sexual violence in emergencies

WORLD HEALTH ORGANIZATION (WHO)
June 2007

Expand view

This document builds on previous WHO publications and explores the different reasons for collecting information about sexual violence in emergency situations. It applies to all forms of enquiry about sexual violence and makes a number of recommendations that are intended to ensure that the necessary safety and ethical safeguards are in place at the beginning of any information gathering exercise. The document sets out the key safety and ethical issues that need to be addressed and the questions that need to be asked. There are examples of good practice and details of further information and resources that are available. This document is not intended to be a standalone guidance document but is designed to complement existing internationally-agreed ethical guidelines for research and to inform ethics review processes

Promoting safety of medicines for children

WORLD HEALTH ORGANIZATION
2007

Expand view

These guidelines are intended to improve awareness of medicine safety issues among everyone who has an interest in the safety of medicines in children and to provide guidance on effective systems for monitoring medicine safety in the paediatric populations. The document will be of interest to all healthcare professionals, medicine regulatory authorities, pharmacovigilance centres, academia, the pharmaceutical industry and policy-makers

Good governance for medicines : assessment instrument

WORLD HEALTH ORGANIZATION (WHO)
2007

Expand view

This briefing describes an assessment instrument that can be used when carrying out a national assessment of transparency and vulnerability to corruption as part of the WHO's programme to promote good governance for medicines

Monitoring and evaluation of mental health policies and plans : mental health policy and service guidance package

WORLD HEALTH ORGANIZATION (WHO)
2007

Expand view

"This module examines key aspects of monitoring and evaluation as they relate to a mental health policy and plan, including how to monitor a plan and the different ways to evaluate a policy and plan. It presents a five-step process for conducting evaluations and explains how results of an evaluation can be utilized to improve policies and plans. The module then provides a detailed case study of a policy and plan of a hypothetical country. It describes various ways that evaluation can be used over a period of time to assess and influence policy and the plan that arises from it, including the practical steps involved in policy evaluation and the policy decisions that can be made on the basis of monitoring and evaluations"
This module is part of the WHO Mental Health Policy and Service Guidance Package. The package consists of a series of interrelated user-friendly modules designed to address the wide variety of needs and priorities in policy development and service planning. Each module addresses a core aspect of mental health

E-bulletin